Concepedia

Shannon L. Black

SL

Statistics

Publications

5

Citations

170

H-Index

5

Active since

2002

Affiliations

Cancer Society of New Zealand(Current)

Pfizer (United States)

University of Auckland

University of Bath

Shannon L. Black is an author at Cancer Society of New Zealand specializing in medicinal chemistry, pharmacology, and ligand binding.

Publications per year

2002–2016

5

Publications

5

Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-<i>d</i>]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family

Jeff B. Smaill, Andrea J. Gonzales, Julie A. Spicer et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +16

4-Anilino-5-carboxamido-2-pyridone Derivatives as Noncompetitive Inhibitors of Mitogen-Activated Protein Kinase Kinase

Julie A. Spicer, Gordon W. Rewcastle, Michael D. Kaufman et al. · Journal of Medicinal Chemistry · 2007 · 50 citations · Full text

, , +13

Probing lipid- and drug-binding domains with fluorescent dyes

Shannon L. Black, Will A. Stanley, Fabian V. Filipp et al. · Bioorganic & Medicinal Chemistry · 2007 · 28 citations · Full text

, , +14

The Role of the Side Chain in Determining Relative δ- and κ-Affinity in C5‘-Substituted Analogues of Naltrindole

Shannon L. Black, Andrew R. Jales, Wolfgang Brandt et al. · Journal of Medicinal Chemistry · 2002 · 17 citations · Full text

, , +15

Guanidino N-Substituted and N,N-Disubstituted Derivatives of the κ-Opioid Antagonist GNTI

Shannon L. Black, Cédric Chauvignac, Peter Grundt et al. · Journal of Medicinal Chemistry · 2003 · 15 citations · Full text

, , +14

1–5 of 5